Hemodynamic, Metabolic and Hormonal Responses to Oral Glibenclamide in Patients with Cirrhosis Receiving Glucose

Background: In patients with cirrhosis, glucose may induce splanchnic and renal vasodilation. Since the antidiabetic sulfonylurea glibenclamide is known to induce splanchnic and renal vasoconstriction in portal hypertensive animals, this drug may inhibit glucose-induced hemodynamic responses in pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of gastroenterology 2001, Vol.36 (3), p.303-308
1. Verfasser: R. Moreau, C. Chagneau, J. Heller, D. Chevenne, P. Langlet, P. Deltenre, S. Hillaire, P. Lefilliatre, D. Pateron, P. Sogni, D. Valla, D. Lebrec
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!